A Third COVID-19 Vaccine Could Have 90% Effectiveness—Thanks to a Trial Error
Some participants were mistakenly given a half dose of the vaccine at first, and then the full dose later—proving more effective than two full doses.

Justin Tallis/Getty
Get the Beast Digest newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
Oxford University and AstraZeneca’s COVID-19 vaccine could be up to 90 percent effective in treating the disease—a discovery made by mistake. Patients were supposed to be given two full doses of the vaccine during the trial, served four weeks apart. However, some participants were mistakenly given a half dose at first, and then the full dose later. Of those given two full doses, the vaccine had 62 percent efficacy, compared to 90 percent for the group given the smaller initial dose. “The reason we had the half dose is serendipity,” said Mene Pangalos, AstraZeneca’s vice president for biopharmaceuticals research and development. While Pfizer and Moderna’s vaccines have higher efficacy rates, with both proving 95 percent effective in trials, AstraZeneca’s vaccine will be cheaper and available for storage at warmer temperatures, according to the Associated Press.
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation